Elite Pharmaceuticals ($ELTP) Insider Trading & Smart Money Activity

Elite Pharmaceuticals, Inc. · Drug Manufacturers - Specialty & Generic · Latest filing Oct 9, 2026

Elite Pharmaceuticals, Inc. ($ELTP) has 1 insider trade on file. In the last 12 months on the open market, 1 insider bought ($25.98K) and no insider sold, net +$25.98K.

Insider buyers (12 mo)
1
Insider sellers (12 mo)
0
Net insider $ (12 mo)
+$25.98K
Congress trades (12 mo)
0
13F moves on file
0
Analyst ratings on file
0

ELTP insider buying and selling by quarter

QuarterInsider buysInsider salesCongress buys / sales13F added / cut
Q1 2026 0 0 0 / 0 0 / 0
Q2 2026 0 0 0 / 0 0 / 0
Q3 2026 0 0 0 / 0 0 / 0
Q4 2026 1 · $25.98K 0 0 / 0 0 / 0

Insider buys and sales count open-market trades only (Form 4 codes P and S). Grants, option exercises and tax withholding are left out.

All ELTP insider, congress, 13F and analyst activity

DateSourceWhoActionSharesValue / amount ΔOwn1W1M6MFilingStory
Insider Barry H DashDirector Buy (Open-market buy) 100K sh $25.98K +3.06% -3.8% SEC Read

1W / 1M / 6M = how ELTP moved from the trade or filing date.

Insider trading in ELTP: who is buying and selling

InsiderRoleTradesOpen-market netShares heldLast trade
Barry H Dash Director 1 +$25.98K 3.37M Oct 9, 2026

Frequently asked questions

Are ELTP insiders buying or selling?

Over the last 12 months 1 insider made 1 open-market purchase worth $25.98K and 0 insiders made 0 open-market sales worth $0, a net +$25.98K.

What is the latest insider trade in ELTP?

Barry H Dash, Director filed a buy (open-market buy) of 100K sh worth $25.98K on Oct 9, 2026.

Other drug manufacturers - specialty & generic stocks

Data comes from public SEC Form 4 and 13F filings and STOCK Act disclosures. Dates are the trade or filing date reported. This page is for research only and is not investment advice.

Get trade alerts by text

SMS Terms

By entering your mobile number and tapping the sign-up button, you provide express written consent to receive recurring automated text messages from TradeTexts at that number, including stock alerts about SEC filings, insider and congress trades, analyst ratings, hedge fund moves, and earnings results. Consent is not a condition of any purchase. Message frequency varies. Messages are not investment advice. Message and data rates may apply. Reply HELP for help and STOP to opt out at any time. See our Terms and Privacy Policy.

Full terms and conditions